Skip to content Skip to sidebar Skip to footer
sigma healthcare
Sigma Healthcare rerating rests on delivering $100m merger synergies
Sigma Healthcare (ASX: SIG) now turns on one fact above all others: the Chemist Warehouse merger has transformed a low-growth wholesaler into a scaled pharmacy retail and distribution group, and management has already lifted the expected synergy prize to $100m a year by FY29 from $60m. That upgrade, announced in October, was the clearest signal…
nextdc
NEXTDC rerates on 296.8MW order book converting into billings through FY29
NEXTDC (ASX: NXT) has moved sharply higher after a run of announcements that changed how much future capacity investors can reasonably expect the company to monetise. The biggest trigger was the 25 February 2026 half-year result, when contracted utilisation jumped 137% to 416.6MW and the forward order book reached 296.8MW, with that capacity expected to convert…

Stocks Down Under (Pitt Street Research AFSL 1265112) provides actionable investment ideas on ASX-listed stocks. This content provides general information only and does not constitute financial advice. Always do your own research before making investment decisions. © 2026 Stock Down Under. All Rights Reserved.

© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here